Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients
Objectives Recent Zika virus (ZIKV) outbreaks challenged existing laboratory diagnostic standards, especially for serology‐based methods. Because of the genetic and structural similarity of ZIKV with other flaviviruses, this results in cross‐reactive antibodies, which confounds serological interpret...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Nature Publishing Group
2019
|
| _version_ | 1826260053914550272 |
|---|---|
| author | Amrun, SN Yee, W-X Abu Bakar, F Lee, B Kam, Y-W Lum, F-M Tan, JJ Lim, VW Watthanaworawit, W Ling, C Nosten, F Renia, L Leo, Y-S Ng, LF |
| author_facet | Amrun, SN Yee, W-X Abu Bakar, F Lee, B Kam, Y-W Lum, F-M Tan, JJ Lim, VW Watthanaworawit, W Ling, C Nosten, F Renia, L Leo, Y-S Ng, LF |
| author_sort | Amrun, SN |
| collection | OXFORD |
| description | Objectives
Recent Zika virus (ZIKV) outbreaks challenged existing laboratory diagnostic standards, especially for serology‐based methods. Because of the genetic and structural similarity of ZIKV with other flaviviruses, this results in cross‐reactive antibodies, which confounds serological interpretations.
Methods
Plasma from Singapore ZIKV patients was screened longitudinally for antibody responses and neutralising capacities against ZIKV. Samples from healthy controls, ZIKV patients and DENV patients were further assessed using ZIKV and DENV peptides of precursor membrane (prM), envelope (E) or non‐structural 1 (NS1) viral proteins in a peptide‐based ELISA for epitope identification. Identified epitopes were re‐validated and diagnostically evaluated using sera of patients with DENV, bacteria or unknown infections from Thailand.
Results
Long‐lasting ZIKV‐neutralising antibodies were elicited during ZIKV infection. Thirteen potential linear B‐cell epitopes were identified, and of these, four common flavivirus, three ZIKV‐specific and one DENV‐specific differential epitopes had more than 50% sensitivity and specificity. Notably, ZIKV‐specific peptide 26 on domain I/II of E protein (amino acid residues 271–288) presented 80% sensitivity and 85.7% specificity. Importantly, the differential epitopes also showed significance in differentiating non‐flavivirus patient samples.
Conclusion
Linear B‐cell epitope candidates to differentiate between ZIKV and DENV infections were identified, providing the first step towards the design of a much‐needed serology‐based assay. |
| first_indexed | 2024-03-06T18:59:31Z |
| format | Journal article |
| id | oxford-uuid:1307a888-a11e-4982-ab82-ec30c65474c9 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:59:31Z |
| publishDate | 2019 |
| publisher | Nature Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:1307a888-a11e-4982-ab82-ec30c65474c92022-03-26T10:11:31ZNovel differential linear B-cell epitopes to identify Zika and dengue virus infections in patientsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1307a888-a11e-4982-ab82-ec30c65474c9EnglishSymplectic ElementsNature Publishing Group2019Amrun, SNYee, W-XAbu Bakar, FLee, BKam, Y-WLum, F-MTan, JJLim, VWWatthanaworawit, WLing, CNosten, FRenia, LLeo, Y-SNg, LFObjectives Recent Zika virus (ZIKV) outbreaks challenged existing laboratory diagnostic standards, especially for serology‐based methods. Because of the genetic and structural similarity of ZIKV with other flaviviruses, this results in cross‐reactive antibodies, which confounds serological interpretations. Methods Plasma from Singapore ZIKV patients was screened longitudinally for antibody responses and neutralising capacities against ZIKV. Samples from healthy controls, ZIKV patients and DENV patients were further assessed using ZIKV and DENV peptides of precursor membrane (prM), envelope (E) or non‐structural 1 (NS1) viral proteins in a peptide‐based ELISA for epitope identification. Identified epitopes were re‐validated and diagnostically evaluated using sera of patients with DENV, bacteria or unknown infections from Thailand. Results Long‐lasting ZIKV‐neutralising antibodies were elicited during ZIKV infection. Thirteen potential linear B‐cell epitopes were identified, and of these, four common flavivirus, three ZIKV‐specific and one DENV‐specific differential epitopes had more than 50% sensitivity and specificity. Notably, ZIKV‐specific peptide 26 on domain I/II of E protein (amino acid residues 271–288) presented 80% sensitivity and 85.7% specificity. Importantly, the differential epitopes also showed significance in differentiating non‐flavivirus patient samples. Conclusion Linear B‐cell epitope candidates to differentiate between ZIKV and DENV infections were identified, providing the first step towards the design of a much‐needed serology‐based assay. |
| spellingShingle | Amrun, SN Yee, W-X Abu Bakar, F Lee, B Kam, Y-W Lum, F-M Tan, JJ Lim, VW Watthanaworawit, W Ling, C Nosten, F Renia, L Leo, Y-S Ng, LF Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients |
| title | Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients |
| title_full | Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients |
| title_fullStr | Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients |
| title_full_unstemmed | Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients |
| title_short | Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients |
| title_sort | novel differential linear b cell epitopes to identify zika and dengue virus infections in patients |
| work_keys_str_mv | AT amrunsn noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT yeewx noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT abubakarf noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT leeb noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT kamyw noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT lumfm noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT tanjj noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT limvw noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT watthanaworawitw noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT lingc noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT nostenf noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT renial noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT leoys noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients AT nglf noveldifferentiallinearbcellepitopestoidentifyzikaanddenguevirusinfectionsinpatients |